Privia Health Group Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Privia Health Group Inc in the third quarter 2026?
Privia Health Group Inc achieved a return on average equity (ROE) of 4.54 % in its third quarter 2026, this is above PRVA's average return on equity of -4.15%.
Privia Health Group Inc shareholder's equity over the 12 months ending in its third quarter 2026 are valued at $827 million

ROE has advanced compared to 4.23% in the second quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 55 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 1361 to 2099.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	14.44 %	14.25 %	13.58 %	15.73 %	-
Y / Y Net Income Change	37.52 %	196.05 %	-38.64 %	97.22 %	146.53 %
Net Income (TTM) in Millions	38	34	27	30	25
Return On Equity (TTM)	4.54 %	4.23 %	3.54 %	3.97 %	3.39 %
PRVA's Total Ranking	# 2099	# 1361	# 1526	# 1920	#
Equity (TTM) in Millions	873	838	806	791	763
Seq. Equity Change	4.16 %	3.99 %	1.89 %	3.69 %	3.98 %
Seq. Net Income Change	38.56 %	162.37 %	-64.95 %	7.93 %	198.27 %

Back to PRVA Management Effectiveness >> PRVA's 5 Years Annual ROE >> Compare PRVA ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 56
Sector	# 169
Overall	# 2099

Return On Equity Statistics
High	Average	Low
6.35 %	-4.15 %	-54.7 %
(Sep 30 2023)		(Dec 31 2021)

PRVA Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	791	683	607	519	450
Y / Y Equity Change	15.73 %	12.52 %	17.02 %	15.3 %	-
Net Income in Millions	30	17	21	-12	-191
Y / Y Net Income Change	74.41 %	-18.95 %	-	-	-
Return On Equity	3.76 %	2.49 %	3.46 %	-2.32 %	-42.35 %

Back to PRVA Management Effectiveness >> PRVA's 5 Years Annual ROE >> Compare PRVA ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 3.76 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PRVA's' Return on Equity at Yahoo Finance
PRVA's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PRVA's Competitors
Subscribers only: Roe for Privia Health Group Inc 's Suppliers
Subscribers only: Return On Equity for PRVA's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Haemonetics Corporation	12.07 %
Labcorp Holdings Inc	11.55 %
Henry Schein Inc	11.29 %
Medinotec Inc	10.97 %
Tactile Systems Technology Inc	10.73 %
Penumbra Inc	10.44 %
Teleflex Incorporated	9.67 %
Merit Medical Systems Inc	9.65 %
U S Physical Therapy Inc	9.48 %
Pacific Health Care Organization Inc	8.10 %
Incyte Corporation	7.08 %
Conmed Corporation	7.07 %
Teva Pharmaceutical Industries Limited	6.37 %
Integer Holdings Corporation	6.02 %
Avantor Inc	5.96 %
Ligand Pharmaceuticals Incorporated	5.22 %
Lifestance Health Group Inc	4.82 %
Jazz Pharmaceuticals Plc	4.62 %
Pfizer Inc	4.62 %
Innovage Holding Corp	4.52 %
Icu Medical Inc	2.81 %
Biogen Inc	1.86 %
Integra Lifesciences Holdings Corp	1.24 %

Date modified: 2026-11-06T13:03:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.